Kidney Transplant Rejection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients [Phase 3]
Phase 3 TACKLE-IT trial investigates treatment for acute T cell rejection in kidney transplant recipients. The study also references a pancr…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: PROACT Pilot Trial
An update on the PROACT Pilot Trial sponsored by the University of British Columbia to investigate treatment for kidney transplant rejection…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Microbiome and Immunosuppression: The Mission Study
The Mission Study investigates the microbiome's role in immunosuppression for kidney transplant patients and is currently ACTIVE_NOT_RECRUIT…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Molecular Landscape of Microvascular Inflammation in Kidney Allografts
A clinical trial investigating the molecular landscape of microvascular inflammation in kidney allografts is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study
This ClinicalTrials.gov entry describes an ongoing single-center prospective cohort study evaluating immune monitoring in kidney transplant …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR
This is a long-term follow-up clinical trial evaluating kidney transplant patients treated with imlifidase or plasma exchange after antibody…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant [Phase 1, Phase 2]
The trial update reports Phase 1/2 results for clazakizumab in chronic and active antibody-mediated rejection after kidney transplantation, …
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection
A clinical trial update investigates longitudinal changes in donor-derived cell-free DNA with tocilizumab treatment for chronic antibody-med…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Transplant Antibody-Mediated Rejection: Guiding Effective Treatments [Phase 3]
A Phase 3 clinical trial evaluating treatments for antibody-mediated rejection in kidney transplant patients has been terminated.
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Impact of the Microbiota on the Likelihood of Renal Graft Rejection
A clinical trial is studying how the gut microbiota affects the likelihood of kidney transplant rejection, and the study is currently recrui…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients [NA]
This clinical trial evaluates how FDG-PET imaging can improve diagnosis and management of subclinical rejection in kidney transplant patient…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Utilising Volumetric Absorptive Microsampling (VAMS) Technology to Monitor Tacrolimus and Creatinine
Clinical trial update on using Volumetric Absorptive Microsampling (VAMS) to monitor tacrolimus and creatinine in kidney transplant patients…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients
This clinical trial investigates plasma and urinary cell-free DNA as biomarkers for kidney transplant rejection. The study is currently recr…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients [Phase 3]
Clinical trial update for a Phase 3 study of tocilizumab in late/chronic active antibody-mediated rejection after kidney transplantation. Th…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Improving KIdney Transplantation with Cellular Therapy Study
A study evaluating cellular therapy to improve kidney transplantation has been terminated.
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: GEnomic Medicine in Kidney Transplantation Study
A genomic medicine study for kidney transplantation is not yet recruiting. It is sponsored by Western Sydney Local Health District and targe…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant [Phase 1, Phase 2]
Clinical trial update on clazakizumab for highly HLA-sensitized patients awaiting kidney transplant; the study spans Phase 1/2 with status A…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation [Phase 2]
A Phase 2 clinical trial update for fingolimod aimed at reducing interstitial fibrosis and tubular atrophy after kidney transplantation, wit…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients [Phase 1]
Phase 1 clinical trial evaluating autologous tolerogenic dendritic cells for highly sensitized kidney transplant recipients; the study is cu…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: PRObiotics for KIdney Transplantation [NA]
A clinical trial update shows enrollment by invitation for a study using probiotics in kidney transplant recipients to address urinary tract…
-
FDA approval · 2025-02-12FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for mycophenolate mofetil from Strides Pharma Science Limited.
-
FDA approval · 2025-02-12FDA Approved: TACROLIMUS — Original Application (Nexus Pharmaceuticals, LLC)
Generic tacrolimus from Nexus Pharmaceuticals has been approved through an original ANDA for use in preventing organ transplant rejection.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients [Phase 1, Phase 2]
Early-phase safety and tolerability study evaluating a chimeric antigen receptor regulatory T cell (CAR-Treg) therapy in living donor kidney…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
This clinical trial update presents results from a follow-up study of patients treated with imlifidase prior to kidney transplantation, eval…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection [NA]
A completed study from Charité University evaluated donor-derived cell-free DNA as an early diagnostic biomarker for antibody-mediated rejec…